These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 192765)

  • 1. Effects of levamisole on normal and abnormal leukocyte locomotion.
    Wright DG; Kirkpatrick CH; Gallin JI
    J Clin Invest; 1977 May; 59(5):941-50. PubMed ID: 192765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective granulocyte chemotaxis in the Chediak-Higashi syndrome.
    Clark RA; Kimball HR
    J Clin Invest; 1971 Dec; 50(12):2645-52. PubMed ID: 4942966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotactic function of polymorphonuclear leukocytes from patients with recurrent infections: partial correction by levamisole "in vitro".
    Stein AN; Díez RA; Sen L; Estévez ME
    Allergol Immunopathol (Madr); 1985; 13(2):127-34. PubMed ID: 4003229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal bactericidal, metabolic, and lysosomal functions of Chediak-Higashi Syndrome leukocytes.
    Root RK; Rosenthal AS; Balestra DJ
    J Clin Invest; 1972 Mar; 51(3):649-65. PubMed ID: 4400956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro stimulation of neutrophil motility by levamisole: maintenance of cgmp levels in chemotactically stimulated levamisole-treated neutrophils.
    Anderson R; Glover A; Koornhof HJ; Rabson AR
    J Immunol; 1976 Aug; 117(2):428-32. PubMed ID: 181491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulated neutrophil locomotion: chemokinesis and chemotaxis.
    Becker EL
    Arch Pathol Lab Med; 1977 Oct; 101(10):509-13. PubMed ID: 199132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective neutrophil motility and recurrent infection. In vitro and in vivo effects of levamisole.
    Rabson AR; Anderson R; Glover A
    Clin Exp Immunol; 1978 Jul; 33(1):142-9. PubMed ID: 709909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil function in surgical patients: in vitro correlation of abnormal neutrophil chemotaxis by Levamisole.
    Christou NV; Meakins JL
    Surgery; 1979 May; 85(5):543-8. PubMed ID: 432816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired neutrophil locomotion associated with hyperadhesiveness in a patient with Chédiak-Higashi syndrome.
    Keller HU; Morell A; Schaffner T; Zimmermann A; Schaad U
    Blood Cells; 1984; 10(1):37-43. PubMed ID: 6487813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotaxis of human leucocytes: II. Effects of lectins, colchicine, cytochalasin B, cyclic nucleotides and immuno-stimulatory products.
    Pham Huu T
    Biomedicine; 1979 Jun; 30(2):121-4. PubMed ID: 224965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the chemotactic response of bovine polymorphonuclear leukocytes by levamisole.
    Jayappa HG; Loken KI
    Am J Vet Res; 1982 Dec; 43(12):2138-42. PubMed ID: 6762119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of neutrophil chemotaxis and alteration of levels of cellular cyclic nucleotides by levamisole.
    Hogan NA; Hill HR
    J Infect Dis; 1978 Oct; 138(4):437-44. PubMed ID: 213494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro effects of histamine and metiamide on neutrophil motility and their relationship to intracellular cyclic nucleotide levels.
    Anderson R; Glover A; Rabson AR
    J Immunol; 1977 May; 118(5):1690-6. PubMed ID: 192799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long-term therapy with sulphasalazine, levamisole, corticosteroids and ascorbic acid and of disease activity on polymorphonuclear leukocyte function in patients with ulcerative colitis.
    Hermanowicz A; Sliwiński Z; Kaczor R
    Hepatogastroenterology; 1985 Apr; 32(2):81-6. PubMed ID: 2861152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction of leukocyte function in Chediak-Higashi syndrome by ascorbate.
    Boxer LA; Watanabe AM; Rister M; Besch HR; Allen J; Baehner RL
    N Engl J Med; 1976 Nov; 295(19):1041-5. PubMed ID: 184391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil function in normal and Chediak-Higashi syndrome cats following administration of recombinant canine granulocyte colony-stimulating factor.
    Colgan SP; Gasper PW; Thrall MA; Boone TC; Blancquaert AM; Bruyninckx WJ
    Exp Hematol; 1992 Nov; 20(10):1229-34. PubMed ID: 1385198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired microtubule function correctable by cyclic GMP and cholinergic agonists in the Chediak-Higashi syndrome.
    Oliver JM
    Am J Pathol; 1976 Nov; 85(2):395-418. PubMed ID: 187062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane fluidity in human and mouse Chediak-Higashi leukocytes.
    Haak RA; Ingraham LM; Baehner RL; Boxer LA
    J Clin Invest; 1979 Jul; 64(1):138-44. PubMed ID: 221541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic suppurative bronchopathy and motility defect of neutrophils: evaluation of an immunomodulating treatment].
    Cazzola GA; Valletta EA; Mastella G
    Pediatr Med Chir; 1989; 11(1):73-5. PubMed ID: 2717488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro effects of propranolol and atenolol on neutrophil motility and post-phagocytic metabolic activity.
    Anderson R; van Rensburg AJ
    Immunology; 1979 May; 37(1):15-24. PubMed ID: 223974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.